Neuropathology Core
神经病理学核心
基本信息
- 批准号:10176345
- 负责人:
- 金额:$ 40.89万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-06-01 至 2025-03-31
- 项目状态:未结题
- 来源:
- 关键词:Alzheimer&aposs DiseaseAlzheimer&aposs disease related dementiaAutopsyAwardBiological AssayBiological MarkersBrainBrain regionClinical DataCognitiveConsensusCountryDataDementiaDevelopmentDiagnosticDisciplineDiseaseEnvironmentEvaluationFacultyFormalinFosteringFreezingFutureGuidelinesImageImpaired cognitionIndividualInterdisciplinary StudyInternationalLeadershipMedical StudentsMethodsMissionMolecularNerve DegenerationNeurodegenerative DisordersOutreach ResearchParaffin EmbeddingPathologicPathologic ProcessesPatientsPhysiciansPositioning AttributeProcessReportingResearchResearch PersonnelResource SharingScientistSpecimenStructureTechniquesTechnologyTimeTissue EmbeddingTissuesTrainingTranslational ResearchVisionaging brainbiobankbrain researchbrain tissuedata managementdata qualityeducation researchgraduate studentimaging approachinnovationinnovative technologiesinsightmolecular pathologyneuropathologyrepositoryresearch studystatistics
项目摘要
1. SUMMARY (Neuropathology Core)
The Neuropathology Core supports the vision of the Stanford Alzheimer’s Disease Center (ADRC) to serve as
a shared resource to facilitate and enhance multidisciplinary and interdisciplinary research in Alzheimer’s
disease (AD) and related disorders. The Core is structured to continue its track record of enabling and applying
innovative cutting-edge technologies with emphasis on brain aging and the diversity of pathologic processes
that underlie cognitive impairment and dementia caused by AD and related diseases. The critical functions of
the Neuropathology Core include diagnostic expertise, serving as a biorepository, facilitating innovation, and
training. Over the past five years, the Neuropathology Core has completed over 50 research brain autopsies
and held a leadership position in setting and evaluating national research guidelines for neuropathologic
evaluation of AD. We have banked over 800 tissue specimens, contributed data and biospecimens to local,
regional, national, and international research studies and consortia, and fostered development and
implementation of innovative technologies in translational research. Through the Core, we trained clinicians
and scientists from different disciplines in neuropathology and the molecular pathology of dementia-related
neurodegenerative diseases. The Neuropathology Core will pursue its mission through four Specific Aims. The
Core will provide comprehensive neuropathologic evaluations for physicians and researchers with timely and
comprehensive autopsy reports that describe the neuropathologic features of AD and related diseases
according to the most current guidelines and consensus diagnostic criteria. It will maintain and continue to
grow its highly accessible, but appropriately safeguarded, repository of brain tissue and biospecimens from
carefully and longitudinally characterized patients with cognitive impairment or dementia, as well as cognitively
normal individuals, using methods that increase and maximize tissue and data quality. In doing so, the Core
will empower innovative high-content imaging approaches for both formalin-fixed, paraffin-embedded tissue
and for frozen brain regions to maximize the research value of the Stanford ADRC repository and other brain
banks around the country. Finally, we will maintain a rich training environment for medical and graduate
students, residents, fellows, and junior faculty across departments to teach concepts and state-of-the-art
techniques that advance current interdisciplinary research and foster future advances and insights in brain
aging and neurodegeneration. The Core is organized to maximize integration with all other Cores in the
Stanford ADRC. It also will continue to serve as a hub of support for affiliated ADRCs and independent
research awards through diagnostic practices, molecular assays, and tissue sharing. In doing so, the Core and
Center will continue to contribute nationally to advance our understanding of the pathologic features and
pathophysiologic processes of brain aging, all stages of AD, and related dementias.
1. 摘要(神经病理学核心)
神经病理学核心支持斯坦福阿尔茨海默病中心 (ADRC) 的愿景:
促进和加强阿尔茨海默病多学科和跨学科研究的共享资源
疾病(AD)和相关疾病的核心旨在继续其启用和应用的记录。
创新的尖端技术,重点关注大脑衰老和病理过程的多样性
这是 AD 及相关疾病引起的认知障碍和痴呆的基础。
神经病理学核心包括诊断专业知识、充当生物储存库、促进创新以及
在过去的五年里,神经病理学核心已经完成了 50 多项脑部尸检研究。
并在制定和评估国家神经病理学研究指南方面发挥了领导作用
我们储存了 800 多个组织样本,为当地提供数据和生物样本。
区域、国家和国际研究和联盟,并促进发展和
通过核心,我们培养了超级明星,以实现转化研究中的创新技术。
以及神经病理学和痴呆相关分子病理学不同学科的科学家
神经退行性疾病。神经病理学核心将通过四个具体目标来追求其使命。
Core 将为医生和研究人员提供及时和全面的神经病理学评估
描述 AD 及相关疾病的神经病理学特征的综合尸检报告
根据最新的指南和共识诊断标准,它将维持并继续。
培养其高度可访问但得到适当保护的脑组织和生物样本库
仔细和纵向地描述患有认知障碍或痴呆的患者,以及
正常个体,使用提高和最大化组织和数据质量的方法,核心。
将为福尔马林固定、石蜡包埋的组织提供创新的高内涵成像方法
以及冷冻大脑区域,以最大限度地发挥斯坦福 ADRC 存储库和其他大脑的研究价值
最后,我们将为医学生和研究生维持丰富的培训环境。
跨部门的学生、住院医师、研究员和初级教师教授概念和最先进的技术
推进当前跨学科研究并促进大脑未来进步和见解的技术
该核心的组织方式是为了最大限度地与所有其他核心整合。
斯坦福 ADRC 还将继续作为附属 ADRC 和独立机构的支持中心。
通过诊断实践、分子分析和组织共享获得研究奖励。
中心将继续在全国范围内做出贡献,以增进我们对病理特征和
大脑衰老、AD 各阶段以及相关痴呆的病理生理过程。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Thomas J Montine其他文献
Thomas J Montine的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Thomas J Montine', 18)}}的其他基金
Project 2: Particle and brain mapping of CSF proteins using elemental reporters with mass spectrometry
项目 2:使用元素报告仪和质谱法对 CSF 蛋白进行粒子和脑图谱分析
- 批准号:
10359193 - 财政年份:2020
- 资助金额:
$ 40.89万 - 项目类别:
Project 2: Particle and brain mapping of CSF proteins using elemental reporters with mass spectrometry
项目 2:使用元素报告仪和质谱法对 CSF 蛋白进行粒子和脑图谱分析
- 批准号:
10573262 - 财政年份:2020
- 资助金额:
$ 40.89万 - 项目类别:
相似国自然基金
基于神经退行性疾病前瞻性队列的新烟碱类杀虫剂暴露对阿尔茨海默病的影响及作用机制研究
- 批准号:
- 批准年份:2022
- 资助金额:53 万元
- 项目类别:面上项目
基于miRNA介导ceRNA网络调控作用的防治阿尔茨海默病及认知障碍相关疾病药物的发现研究
- 批准号:
- 批准年份:2020
- 资助金额:55 万元
- 项目类别:面上项目
LMTK1调控核内体转运介导阿尔茨海默病神经元Reserve机制研究
- 批准号:81903703
- 批准年份:2019
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
基于自组装多肽纳米探针检测蛋白标志物用于阿尔茨海默病精准诊断的研究
- 批准号:31900984
- 批准年份:2019
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
靶向干预CD33/Aβ相互作用改善小胶质细胞功能延缓AD病理进程
- 批准号:81901072
- 批准年份:2019
- 资助金额:20.5 万元
- 项目类别:青年科学基金项目
相似海外基金
Uncovering Mechanisms of Racial Inequalities in ADRD: Psychosocial Risk and Resilience Factors for White Matter Integrity
揭示 ADRD 中种族不平等的机制:心理社会风险和白质完整性的弹性因素
- 批准号:
10676358 - 财政年份:2024
- 资助金额:
$ 40.89万 - 项目类别:
Small Molecule Degraders of Tryptophan 2,3-Dioxygenase Enzyme (TDO) as Novel Treatments for Neurodegenerative Disease
色氨酸 2,3-双加氧酶 (TDO) 的小分子降解剂作为神经退行性疾病的新疗法
- 批准号:
10752555 - 财政年份:2024
- 资助金额:
$ 40.89万 - 项目类别:
The Influence of Lifetime Occupational Experience on Cognitive Trajectories Among Mexican Older Adults
终生职业经历对墨西哥老年人认知轨迹的影响
- 批准号:
10748606 - 财政年份:2024
- 资助金额:
$ 40.89万 - 项目类别:
The Proactive and Reactive Neuromechanics of Instability in Aging and Dementia with Lewy Bodies
衰老和路易体痴呆中不稳定的主动和反应神经力学
- 批准号:
10749539 - 财政年份:2024
- 资助金额:
$ 40.89万 - 项目类别: